Health Care & Life Sciences » Pharmaceuticals | DAE HWA Pharmaceutical Co. Ltd.

DAE HWA Pharmaceutical Co. Ltd. | Ownership

Companies that own DAE HWA Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
VIP Research & Management Inc.
1,742,841
9.56%
1,742,841
8.84%
04/06/2017
The Vanguard Group, Inc.
258,967
1.42%
218
0%
07/31/2018
Dimensional Fund Advisors LP
132,969
0.73%
64,082
0%
04/30/2018
Norges Bank Investment Management
65,222
0.36%
-60,618
0%
12/31/2017
BlackRock Advisors (UK) Ltd.
35,217
0.19%
0
0%
09/05/2018
Mirae Asset Global Investments Co., Ltd.
25,162
0.14%
6,027
0.01%
04/30/2018
Charles Schwab Investment Management, Inc.
11,978
0.07%
0
0%
09/06/2018
SSgA Funds Management, Inc.
9,950
0.06%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
6,551
0.04%
0
0%
03/31/2018
BlackRock Fund Advisors
6,079
0.03%
0
0%
09/05/2018

About DAE HWA Pharmaceutical Co.

View Profile
Address
495 Hanu-ro
Hoengseong-gun GA 25228
Korea, Republic Of
Employees -
Website http://www.dhpharm.co.kr
Updated 09/14/2018
DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmaceuticals Manufacturing and Distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials Manufacturing and Distribution. Its products include cough suppressants, expectorants, and mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids, and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections.